AzTrials
AzTrials

Post-COVID-19 SyndromeNCT07545499

Physical Functions and Lifestyle Behaviours in Post-COVID-19 Syndrome Based on Circadian Rhythms

An observational study of Post-COVID-19 Syndrome, run by Hacettepe University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Post-COVID-19 syndrome is associated with persistent symptoms such as fatigue, reduced physical activity, and impaired respiratory function. Circadian rhythm differences (chronotype) may influence lifestyle behaviors including physical activity, nutrition, and sleep patterns. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Post-COVID-19 Syndrome
How many people
50 participants
Where
1 siteTurkey (Türkiye)
Study dates
22 May 2025to 22 May 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population consists of post-COVID-19 syndrome patients aged 18-65 years who are referred to the Hacettepe University Cardiopulmonary Rehabilitation Unit. Participants will be classified into morning-type and evening-type chronotypes.

Who may be able to join

  • Diagnosed with Post-COVID-19 Syndrome
  • Aged between 18-65 years
  • Able to read and understand Turkish
  • Voluntary participation
  • Classified as Post-Covid Functional Status Scale (PCFS) grade 2-3
  • Clinically stable condition
  • No uncontrolled comorbidities (e.g., hypertension, diabetes under control)
  • No orthopedic or neurological conditions affecting exercise testing

Who cannot join

  • Recent myocardial infarction or pulmonary embolism
  • Severe uncontrolled chronic diseases
  • Neurological or orthopedic conditions limiting mobility
  • Psychiatric or neurological disorders affecting cooperation or test compliance
  • Inability to complete assessments

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ebru Çalık, Professor contact

+905442850087

ecalik85@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Hacettepe University Faculty of Physical Therapy and Rehabilitation

    Ankara, Altindağ, 06100

    EBRU ÇALIK, Professor, +905442850087, ecalik85@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Respiratory Muscle Strength, Physical Activity Level, and Dietary Habits in Individuals With Post-COVID-19 Syndrome Having Different Circadian Rhythms

Post-COVID-19 syndrome is associated with persistent symptoms such as fatigue, reduced physical activity, and impaired respiratory function. Circadian rhythm differences (chronotype) may influence lifestyle behaviors including physical activity, nutrition, and sleep patterns.

This observational cross-sectional study aims to compare respiratory muscle strength, physical activity levels, and nutritional habits among individuals with post-COVID-19 syndrome according to their chronotype (morning, intermediate, and evening types).

Additionally, genetic analysis of the CLOCK gene polymorphism will be performed to support objective evaluation of circadian rhythm differences. The findings of this study may help to better understand the role of circadian rhythm in post-COVID-19 syndrome and contribute to the development of individualized rehabilitation and lifestyle interventions.

Read the detailed description

Post-COVID-19 syndrome is characterized by persistent symptoms such as fatigue, reduced exercise tolerance, and impaired respiratory function following acute SARS-CoV-2 infection. Emerging evidence suggests that circadian rhythm disruption may play a role in the pathophysiology of these symptoms by affecting metabolic regulation, hormonal balance, sleep quality, and physical performance.

Circadian rhythm varies between individuals and is commonly classified into chronotypes as morning, intermediate, and evening types. These chronotypes are associated with differences in daily activity patterns, nutritional behaviors, and physiological performance.

The aim of this observational cross-sectional study is to compare respiratory muscle strength, physical activity levels, nutritional habits, sleep quality, fatigue perception, and gastrointestinal symptoms in individuals with post-COVID-19 syndrome according to their chronotype.

Participants aged 18-65 years with a confirmed diagnosis of post-COVID-19 syndrome will be included. Chronotype will be assessed using the Munich Chronotype Questionnaire (MCTQ). Respiratory muscle strength will be evaluated using maximal inspiratory and expiratory pressures (MIP/MEP), and dynamic respiratory parameters will be assessed using a POWERbreathe device. Respiratory muscle endurance will be measured using threshold loading protocols.

Physical activity levels will be assessed using the International Physical Activity Questionnaire (IPAQ), while nutritional intake will be evaluated using 24-hour dietary recall. Sleep quality, fatigue severity, and gastrointestinal symptoms will be assessed using validated questionnaires.

In addition, blood samples will be collected for genetic analysis of the CLOCK gene polymorphism (rs1801260) using PCR-RFLP techniques to provide an objective assessment of circadian rhythm differences.

This study is expected to provide comprehensive insight into the relationship between circadian rhythm and functional, behavioral, and physiological outcomes in post-COVID-19 syndrome, and may contribute to the development of individualized rehabilitation strategies.

Keywords
Circadian Rhythm, Chronotype, Respiratory Muscle Strength, Physical Activity, Nutrition, Post-COVID, Long COVID, CLOCK Gene, Genetic Polymorphism
Medical subject headings
Post-Acute COVID-19 Syndrome, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07545499
Study groupRoleWhat they receive
Morning Types (Larks)People who wake up early, feel most energetic in the morning, and reach their peak performance early in the day.
Evening Types (Owls)People who stay up late, struggle with early mornings, and reach their peak functional capacity in the late afternoon or evening.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Respiratory Muscle Strength

    Maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP) values will be recorded with mouth pressure device.

    Measured: Time Frame: Day 1

  2. Dynamic respiratory muscle strength

    Respiratory muscle strength index (S index) will be assessed using a portable POWERbreathe K5 device.

    Measured: Time Frame: Day 1

  3. Respiratory muscle endurance

    Respiratory muscle endurance test at constant threshold load will be used.

    Measured: Time Frame: Day 1

Secondary outcomes (7)
  1. Physical Activity Level

    Physical activity levels will be assessed using the International Physical Activity Questionnaire Short Form (IPAQ-SF), expressed as MET-min/week.

    The total weekly IPAQ score (MET-min/week) were then used to classify participants into three categories:

    Low PA (individuals who did not meet criteria for moderate or high categories); Moderate PA (≥3 days of vigorous-intensity activity of at least 20 min per day; ≥5 days of moderate-intensity activity and/or walking of at least 30 min per day; or 3-5 or more days of any combination of walking, moderate-intensity or vigorous intensity activities achieving a minimum total PA of at least 600 MET-min/week); high PA (vigorous activity on at least 3 days with a minimum total PA of at least 1500 MET-min/week or 7 days of any combination of walking and moderate or vigorous activities with a minimum total PA of 3000 MET-min/week).

    Measured: Time Frame: Day 1

  2. Dietary Intake

    Dietary intake will be assessed using 24-hour dietary recall records analyzed for macro and micronutrient intake.

    Measured: Time Frame: Day 1

  3. Chronotype Classification

    Chronotype will be determined using the Munich Chronotype Questionnaire (MCTQ), categorizing participants into morning-type and evening-type groups.Total MCTQ scores can range from 16 to 86, with the lowest values representing extreme-late chronotypes.

    Measured: Time Frame: Day 1

  4. Fatigue Severity

    Fatigue will be assessed using the Fatigue Severity Scale (FSS). Total FSS score ranges between 0-7. Total FSS score 4 and more indicates severe fatigue.

    Measured: Time Frame: Day 1

  5. Gastrointestinal Symptoms

    Gastrointestinal symptoms will be evaluated using the Gastrointestinal Symptom Rating Scale (GSRS).The total GSRS score ranges from 15 to 105, with higher scores indicating more severe gastrointestinal symptoms.

    Measured: Time Frame: Day 1

  6. Sleep Quality

    Sleep quality will be evaluated using the Pittsburgh Sleep Quality Index (PSQI). Total PSQI score ranges from 0 to 21, with higher scores indicating poorer sleep quality. A total score greater than 5 is widely used as the cutoff, suggesting poor sleep quality.

    Measured: Time Frame: Day 1

  7. Classificationof human faeces forms

    Classification of human faeces forms will be evaluated using the Bristol Stool Scale.The seven types of stool are recorded by this scale.

    Type 1: Separate hard lumps, like nuts (difficult to pass) Type 2: Sausage-shaped, but lumpy Type 3: Like a sausage but with cracks on its surface Type 4: Like a sausage or snake, smooth and soft (average stool) Type 5: Soft blobs with clear cut edges Type 6: Fluffy pieces with ragged edges, a mushy stool (diarrhea) Type 7: Watery, no solid pieces, entirely liquid (diarrhea)

    Measured: Time Frame: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2026
  2. Study start22 May 2025
  3. Primary completion22 Aug 2026 (estimated)
  4. Study completion22 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07545499
Sponsor's protocol ID
FTREK25/33
Status last verified
Apr 2026
First submitted
14 Apr 2026
Last updated
22 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Suwazono Y, Dochi M, Sakata K, Okubo Y, Oishi M, Tanaka K, Kobayashi E, Kido T, Nogawa K. A longitudinal study on the effect of shift work on weight gain in male Japanese workers. Obesity (Silver Spring). 2008 Aug;16(8):1887-93. doi: 10.1038/oby.2008.298. Epub 2008 Jun 5.

    PubMed 18535539
  • Voigt RM, Forsyth CB, Green SJ, Engen PA, Keshavarzian A. Circadian Rhythm and the Gut Microbiome. Int Rev Neurobiol. 2016;131:193-205. doi: 10.1016/bs.irn.2016.07.002. Epub 2016 Sep 6.

    PubMed 27793218

Questions about this trial

What is this clinical trial studying?

An observational study of Post-COVID-19 Syndrome, run by Hacettepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ebru Çalık, Professor (+905442850087, ecalik85@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Respiratory Muscle Strength (time frame: Time Frame: Day 1). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07545499, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in